Document is current
Any future updates will be listed below
-
Authors
Triska, J.
Uretsky, B. F.
Pitt, B.
Birnbaum, Y.
- License Information
-
More Information
Article History
Accepted: 1 November 2021
First Online: 8 November 2021
Declarations
:
: Jeffrey Triska: None.Barry Uretsky: None.Bertram Pitt: Bayer; AstraZeneca; Boehringer Ingelheim/Lilly; stock options in Vifor Pharmaceuticals, SQinnovations, G3pharmaceuticals, Cereno Scientific, Tricida, Sarfez Pharmaceutical Inc., KBP Biosciences, Protonintel, Brainstorm Medical, PhaseBio Pharmaceuticals, Inc.; stock holder in Tricida, Us patent: 9831412—site-specific delivery of eplerenone to the myocardium, USP patent pending: 63,045783—histone acetylation for the prevention and treatment of organ damage.Yochai Birnbaum: Research grant for AstraZeneca.
